{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_3585c846631a1b7b328f896eb91d69953a2c6bb9b3f4ec94b4902d23bb4f3d67","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_3585c846631a1b7b328f896eb91d69953a2c6bb9b3f4ec94b4902d23bb4f3d67","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"666702bde08fba709fcdd8714daaea8475d166a31e0fc832f86d0c998e87c7f3","published":"Sat, 06 Jun 2026 00:00:00 -0400","receipt_hash":"666702bde08fba709fcdd8714daaea8475d166a31e0fc832f86d0c998e87c7f3","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"666702bde08fba709fcdd8714daaea8475d166a31e0fc832f86d0c998e87c7f3","observed_at":"2026-06-06T04:43:19.193968Z","parent_run_hash":"550d5b02674822f43975c282be668ca76a4d9c7c957eb1601ba8b07dcb67715e","published":"Sat, 06 Jun 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2606.06207v1 Announce Type: new \nAbstract: Veterinary pharmacovigilance systems are essential for monitoring adverse drug events (ADEs), yet existing approaches often fail to capture region-specific toxicity patterns shaped by local biological and regulatory contexts. In Japan, these challenges are amplified by species-specific metabolic differences and reporting practices defined by the Ministry of Agriculture, Forestry, and Fisheries (MAFF). Most prior work relies on prediction-oriented models, limiting mechanistic interpretability. This study proposes a regulatory-integrated unsupervised framework for pattern discovery using the National Veterinary Assay Laboratory (NVAL) database. ADEs are encoded into organ system-aligned representations and adjusted for species-specific reporting biases, enabling cross-species comparison. Similarity-based clustering and dimensionality reduction are applied to identify latent toxicity structures. Analysis of 4,120 high-confidence ADE reports","title":"Unsupervised Pattern Analysis in Japanese Veterinary Toxicology: A Regulatory-Compliant Framework for Cross-Species Risk Assessment","url":"https://arxiv.org/abs/2606.06207","vendor":"arxiv_cs_ai"},"summary":"arXiv:2606.06207v1 Announce Type: new \nAbstract: Veterinary pharmacovigilance systems are essential for monitoring adverse drug events (ADEs), yet existing approaches often fail to capture region-specific toxicity patterns shaped by local biological and regulatory contexts. In Japan, these challenges are amplified by species-specific metabolic differences and reporting practices defined by the Ministry of Agriculture, Forestry, and Fisheries (MAFF). Most prior work relies on prediction-oriented models, limiting mechanistic interpretability. This study proposes a regulatory-integrated unsupervised framework for pattern discovery using the National Veterinary Assay Laboratory (NVAL) database. ADEs are encoded into organ system-aligned representations and adjusted for species-specific reporting biases, enabling cross-species comparison. Similarity-based clustering and dimensionality reduction are applied to identify latent toxicity structures. Analysis of 4,120 high-confidence ADE reports","title":"Unsupervised Pattern Analysis in Japanese Veterinary Toxicology: A Regulatory-Compliant Framework for Cross-Species Risk Assessment","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-06-06T04:43:19Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2606.06207"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:96e4a1d18d14a43668acfdadeea744e745bef3a3750692719912e96c0c4e225b5ef5f32295ac9e221f9784f0208dd7902cc6c7b79c5534eeeb2013a3324ba006","signer":"crovia.substrate","subject":{"observed_at":"2026-06-06T04:43:19Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2606.06207"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"21ae9c218fbee09ed1ad21a83e7df14aa95dbcf6d7ee646eff5e4c82ac57dc6b","leaf_index":219223,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"b82c924a9663e35c9763740343170140ce395aaac32f27e353b4ea6cf82f18f8","side":"left"},{"sibling":"5d05d039f19d99f7bb7a94e8881f03ff56178afbef298c8ebd0ac09a7699b7ec","side":"left"},{"sibling":"e63ef64879141ad4b11c2dc3dc4e4fa5b7b836fffe7036391977afb42b476d1e","side":"left"},{"sibling":"fd9575f6a948714c1130b95611448d61f4fdc06ee3fa9ceac87178a2637d6086","side":"right"},{"sibling":"c0616cd686a7d38739929a6b6198928931be6abaab4234cb997a6de4159373b3","side":"left"},{"sibling":"54a29ea507e360ebe80a86f0756bc1afaf2a0bae92bafa210f0b67fa7c7e821e","side":"right"},{"sibling":"63213cfb37562a3ef2d70c7ab846d4203323a4985a9908a7078e73d8d4ab2f65","side":"left"},{"sibling":"8f35ffd1b994bec37a9cc24e0047790f92b64b006d85bef48f319d6d28a40687","side":"right"},{"sibling":"bd0dfa76bed61a2c5e95135a7304a2b8c4fd064958dbf768664232880d0abaa5","side":"right"},{"sibling":"84d2509eab51047589142ed6da8c496305d2fbcbe148e0e6755163db2c7a4bc4","side":"right"},{"sibling":"9e3ea17e834fab022f2eabcfedb8ea0ac95c1f9fb57edc5004dded68522d3c9e","side":"right"},{"sibling":"41d58fea95a95071715ee23ef8bcd15f5867a3639da28e62a0641bc95eb83094","side":"left"},{"sibling":"27ad9d6a9ab792d708709017242a61b9ca519da4e035f87a342811aae221d000","side":"left"},{"sibling":"5f303e2a7840c60038ff2d035b1cd911feefb0fba880de2d737c6671ace594d4","side":"right"},{"sibling":"b2590791b920ca2a4ed39de126d2c0b1a10d9e7e62f572f12425f214e767b6e1","side":"left"},{"sibling":"1a61eadbf0217d063ab78291ccafdc0c92907f7d6ccdc3357534ef89f07d78ae","side":"right"},{"sibling":"c300cf0154c136afc09b1702a0be98f4ba5b6dc5cf57e8cc714ec1eaf4196eff","side":"left"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":219672,"merkle_root":"d3e32d3a61ca02ce6b1f0b2db86721107770b250e8a5bf762a2c225d2f03c870","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260606T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-06-06T05:38:35Z","sig_algorithm":"ed25519","signature":"dab214c2d4d857f01383c8e93a521a774b1aba60eaee5677d4e43e4074f0342b2c6a9b9bfcff0eba74f7ac81fcb490dd0e43727979c1a7e8979c7e11547fb101","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_3585c846631a1b7b328f896eb91d69953a2c6bb9b3f4ec94b4902d23bb4f3d67"}}